Atherotech Diagnostics Lab Expands Heart Disease Risk Assessment with AspirinWorks® Test

March 27, 2013

Test measures protective effect of aspirin therapy to better assess heart attack and stroke risk

BIRMINGHAM, Ala. – March 27, 2013 – Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, recently launched the AspirinWorks® Test to complement its menu of cardiovascular disease risk assessment tests. Read More… Click Here